Opinion|Videos|March 11, 2025
Optimizing Treatment Sequencing in Advanced Colorectal Cancer
Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + tipiracil ± bevacizumab, and explore the further research needed to understand optimal sequencing of these treatments better.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What additional factors do you consider when determining the most effective sequence of these therapies (fruquintinib, regorafenib, trifluridine + tipiracil ± bevacizumab)?
- What further research is needed to understand optimal sequencing of these therapies better?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
3
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
4
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
5